查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1961293

消化系統支架市場－全球產業規模、佔有率、趨勢、機會、預測：按產品類型、應用、地區和競爭對手分類，2021-2031年

Gastrointestinal Stents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球胃腸道支架市場預計將從 2025 年的 5.5719 億美元成長到 2031 年的 7.7178 億美元，複合年成長率為 5.58%。

這些可擴張的管狀裝置通常由金屬或塑膠製成，旨在恢復消化道（例如膽管、結腸和食道）阻塞部位的管腔通暢性。市場成長的主要促進因素包括全球消化器官系統惡性腫瘤發生率的上升以及老年人口的成長，老年人本身就更容易發生胃腸道阻塞。此外，臨床上向微創內視鏡手術的轉變，與傳統手術相比，微創內視鏡手術的恢復時間更短，這也是推動產品需求的主要因素。

市場概覽
預測期 2027-2031
市場規模：2025年 5.5719億美元
市場規模：2031年 7.7178億美元
複合年成長率：2026-2031年 5.58%
成長最快的細分市場 胃癌
最大的市場 北美洲

儘管存在這些市場促進因素，但由於術後併發症（例如腫瘤生長、支架移位和阻塞）等問題，市場仍面臨重大障礙，這可能會阻礙其廣泛應用。相關疾病的嚴重負擔凸顯了有效處理阻塞的重要性。例如，美國癌症協會估計，到2025年，美國將新增154,270例大腸癌病例。如此龐大的病例數凸顯了對可靠的支架治療方案的迫切需求，以有效處理阻塞並提高患者的生活品質。

市場促進因素

推動全球胃腸道支架市場成長的主要因素是胃腸道癌症（尤其是食道癌和膽道癌）發生率的上升。這些癌症需要姑息性支架置入術來恢復管腔通暢性。隨著全球胃腸道癌症負擔的加重，臨床上對有效工具的需求日益成長，這些工具能夠幫助無法手術切除的腫瘤患者緩解吞嚥困難和阻塞等症狀。根據美國癌症協會於2025年1月發布的《2025年癌症事實與數據》報告，預計僅在美國就將新增約22,070例食道癌病例，這一數字直接增加了對耐用支架解決方案的需求，因為支架是癌症支持治療的關鍵組成部分。

同時，隨著醫療機構逐漸拋棄傳統開放性手術，微創內視鏡技術的日益普及也推動了市場的發展。先進支架設計的研發進一步促進了這一轉變，這些設計能夠實現更精準的放置並減少併發症，從而提高了手術量。該領域的經濟實力體現在主要企業的業績上。例如，波士頓科學公司在2025年2月發布的2024會計年度第四季及全年業績報告中顯示，其醫療外科部門（包括內視鏡產品組合）的淨銷售額成長了12.4%。此外，Olympus在2025會計年度財務報告中錄得調整後營業利潤1885億日元，充分展現了這些醫療技術所創造的巨大經濟價值。

市場挑戰

胃腸道支架術後併發症是市場成長的主要障礙，尤其是支架移位、腫瘤侵犯和阻塞。這些不利事件通常需要再次干預，加重患者的身體負擔，並增加醫療保健系統的經濟成本。當支架因移位或組織增生而無法維持管腔通暢性時，人們會認為這些裝置的可靠性降低，導致醫療專業人員在建議使用支架治療阻塞時更加謹慎。這可能會限制手術數量，並可能減緩支架的整體臨床應用。

由於需要膽汁排放的疾病高發生，這些併發症的影響進一步加劇。在這種情況下，器械故障可能造成特別嚴重的危害。根據美國臨床腫瘤學會 (ASCO) 估計，到 2024 年，美國將有 66,440 名成年人被診斷出罹患胰臟癌。由於胰臟惡性腫瘤常常導致膽道阻塞，需要置入支架，因此，在如此龐大的患者群體中，阻塞或移位的風險持續存在，這嚴重削弱了市場信心。這些不利事件的發生頻率繼續限制胃腸道支架市場的快速擴張。

市場趨勢

腔內連接金屬支架（LAMS）的出現徹底改變了膽道阻塞和胰液儲存的治療方式，實現了無需傳統手術的治療性引流。這些特殊的啞鈴狀裝置可在胃腸道與相鄰管腔之間建立穩定、臨時的通道，顯著簡化了諸如管壁壞死等疾病的治療。關鍵器材的商業性成功推動了介入治療的普及。 2025年2月，波士頓科學公司在其2024年第四季及全年財務報告中宣布，其內視鏡外科業務部門實現了兩位數的成長。這項績效主要歸功於AXIOS支架平台的持續推廣應用以及日本膽囊引流應用領域監管核准的擴大。

同時，生物可吸收和生物可分解支架的應用日益增多，旨在避免二次取出手術，並減少長期器械相關併發症。這些先進的支架設計為在維持管腔通暢性一段時間後逐漸溶解，從而降低永久性塑膠或金屬支架常見的組織侵入和支架移位風險。隨著這些器械臨床療效的證實，它們在標準治療中的應用正在加速。例如，2025年發表於《Frontline Gastroenterology》的一篇題為「ERCP中生物可分解支架的應用：來自高發病率機構的啟示」的論文，詳細介紹了一項對132例患者的回顧性研究，證實了這些可溶解支架在治療複雜膽道和胰管疾病方面的有效性，並確認了它們在減輕再次手術負擔方面的作用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：消化道支架全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品種類（膽道支架、結腸支架、十二指腸支架、食道支架、胰臟支架）
    • 依應用領域（膽道疾病、大腸癌、胃癌、發炎性腸道疾病等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美胃腸支架市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲胃腸道支架市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區消化支架市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲消化支架市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲消化支架市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球消化道支架市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Boston Scientific Corporation
  • Cook Group Inc.
  • Becton Dickinson & Co Ltd
  • CONMED Corporation
  • Cantel Medical LLC
  • ELLA-CS, sro
  • Hobbs Medical Inc.
  • Merit Medical Systems, Inc.
  • Olympus Corp.
  • Diagmed Healthcare Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20621

The Global Gastrointestinal Stents Market is projected to expand from USD 557.19 Million in 2025 to USD 771.78 Million by 2031, reflecting a compound annual growth rate of 5.58%. These expandable tubular devices, generally constructed from metal or plastic, are engineered to re-establish luminal patency in blocked sections of the digestive tract, such as the biliary tree, colon, and esophagus. Market growth is principally driven by the increasing global prevalence of gastrointestinal malignancies and a growing elderly population that is inherently more prone to digestive blockages. Additionally, the clinical transition toward minimally invasive endoscopic procedures, which provide faster recovery times compared to conventional surgery, acts as a key catalyst for product demand.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 557.19 Million
Market Size 2031USD 771.78 Million
CAGR 2026-20315.58%
Fastest Growing SegmentStomach Cancer
Largest MarketNorth America

Despite these drivers, the market faces significant hurdles due to post-procedural complications like tumor ingrowth, stent migration, and occlusion, which can hinder broader adoption. The critical need for effective obstruction management is underscored by the heavy burden of associated diseases; for instance, the American Cancer Society estimated that 154,270 new cases of colorectal cancer would be diagnosed in the United States in 2025. This substantial volume of diagnoses highlights the urgent necessity for reliable stenting solutions to manage obstructions effectively and enhance the quality of life for patients.

Market Driver

The primary factor accelerating the Global Gastrointestinal Stents Market is the rising incidence of gastrointestinal cancers, specifically esophageal and biliary malignancies, which require palliative stenting to restore luminal patency. As the global burden of digestive cancers grows, there is an intensified clinical need for effective tools to manage symptoms like dysphagia and blockages in patients with inoperable tumors. According to the 'Cancer Facts & Figures 2025' report released by the American Cancer Society in January 2025, approximately 22,070 new cases of esophageal cancer were projected to be diagnosed in the United States alone, a figure that directly increases the demand for durable stenting solutions as a vital part of supportive oncology care.

Simultaneously, the market is being propelled by a growing preference for minimally invasive endoscopic techniques as healthcare providers move away from traditional open surgeries. This shift is supported by the development of advanced stent designs that allow for more precise placement and fewer complications, thereby encouraging higher procedure volumes. The economic strength of this sector is reflected in the performance of major industry players; for example, Boston Scientific reported a 12.4% increase in net sales for its MedSurg segment, which includes its endoscopy portfolio, in its 'Fourth Quarter and Full Year 2024 Financial Results' in February 2025. Furthermore, Olympus recorded an adjusted operating profit of ¥188.5 billion in its 2025 fiscal year results, demonstrating the significant economic value generated by these medical technologies.

Market Challenge

A critical obstacle impeding market growth involves the post-procedural complications associated with gastrointestinal stents, particularly stent migration, tumor ingrowth, and occlusion. These adverse events frequently require repeat interventions, which increase the physical strain on patients and add financial costs to healthcare systems. When stents fail to maintain luminal patency due to displacement or tissue overgrowth, the perceived reliability of these devices diminishes, leading healthcare providers to exercise caution in recommending stenting for obstruction management, which potentially limits procedural volumes and slows overall clinical adoption.

The impact of these complications is exacerbated by the high prevalence of conditions requiring biliary drainage, where device failure can be especially detrimental. According to the American Society of Clinical Oncology, an estimated 66,440 adults in the United States were diagnosed with pancreatic cancer in 2024. Since pancreatic malignancies often cause biliary obstructions that necessitate stenting, the persistent risk of occlusion or migration within such a large patient population creates a significant barrier to market confidence, with the frequency of these adverse events continuing to restrain the aggressive expansion of the gastrointestinal stents market.

Market Trends

The emergence of Lumen-Apposing Metal Stents (LAMS) is revolutionizing the management of biliary obstructions and pancreatic fluid collections by enabling therapeutic drainage without the need for traditional surgery. These specialized dumbbell-shaped devices establish a stable, temporary conduit between the gastrointestinal tract and adjacent cavities, significantly simplifying procedures for conditions such as walled-off necrosis. This shift toward interventional solutions is evidenced by the commercial success of leading device platforms; in February 2025, Boston Scientific reported in its 'Fourth Quarter and Full Year 2024 Financial Results' that its endoluminal surgery franchise achieved double-digit growth, a performance attributed to the sustained adoption of the AXIOS stent platform and its expanded regulatory approval for gallbladder drainage in Japan.

In parallel, the adoption of bioresorbable and biodegradable stents is increasing as a solution to eliminate the need for secondary removal procedures and reduce long-term device-related complications. These advanced stents are engineered to maintain luminal patency for a specific period before gradually dissolving, thereby mitigating risks such as tissue ingrowth and stent migration that are frequently associated with permanent plastic or metal alternatives. The clinical validation of these devices is accelerating their integration into standard practice; for instance, a 2025 article in Frontline Gastroenterology titled 'Use of biodegradable stents in ERCP: lessons from a single high-volume centre' detailed a retrospective study of 132 patients that demonstrated the effectiveness of these dissolving stents for complex biliary and pancreatic indications, confirming their utility in lowering the burden of repeat interventions.

Key Market Players

  • Boston Scientific Corporation
  • Cook Group Inc.
  • Becton Dickinson & Co Ltd
  • CONMED Corporation
  • Cantel Medical LLC
  • ELLA-CS, s.r.o.
  • Hobbs Medical Inc.
  • Merit Medical Systems, Inc.
  • Olympus Corp.
  • Diagmed Healthcare Ltd.

Report Scope

In this report, the Global Gastrointestinal Stents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gastrointestinal Stents Market, By Product Type

  • Biliary Stent
  • Colonic Stent
  • Duodenal Stent
  • Esophageal Stent
  • Pancreatic Stent

Gastrointestinal Stents Market, By Application

  • Biliary Disease
  • Colorectal Cancer
  • Stomach Cancer
  • Inflammatory Bowel Disease
  • Others

Gastrointestinal Stents Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gastrointestinal Stents Market.

Available Customizations:

Global Gastrointestinal Stents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gastrointestinal Stents Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent)
    • 5.2.2. By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Gastrointestinal Stents Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Gastrointestinal Stents Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Gastrointestinal Stents Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Gastrointestinal Stents Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application

7. Europe Gastrointestinal Stents Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Gastrointestinal Stents Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Gastrointestinal Stents Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Gastrointestinal Stents Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Gastrointestinal Stents Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Gastrointestinal Stents Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Gastrointestinal Stents Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Gastrointestinal Stents Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Gastrointestinal Stents Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Gastrointestinal Stents Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Gastrointestinal Stents Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Gastrointestinal Stents Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Gastrointestinal Stents Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Gastrointestinal Stents Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Gastrointestinal Stents Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Gastrointestinal Stents Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application

10. South America Gastrointestinal Stents Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Gastrointestinal Stents Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Gastrointestinal Stents Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Gastrointestinal Stents Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Gastrointestinal Stents Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Boston Scientific Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cook Group Inc.
  • 15.3. Becton Dickinson & Co Ltd
  • 15.4. CONMED Corporation
  • 15.5. Cantel Medical LLC
  • 15.6. ELLA-CS, s.r.o.
  • 15.7. Hobbs Medical Inc.
  • 15.8. Merit Medical Systems, Inc.
  • 15.9. Olympus Corp.
  • 15.10. Diagmed Healthcare Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer